1st Quarter - Report
ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for CELGENE CORPORATION
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General FDA issues. H.R. 1409 - The Cancer Drug Parity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE | — |
| AMY JENSEN CUNNIFFE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.